Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ITEK
Delisted

Inotek Pharmaceuticals Corporation Fund Price (Quote)

$3.04
+0 (+0%)
At Close: Jan 22, 2018

Range Low Price High Price Comment
30 days $2.52 $3.25 Monday, 22nd Jan 2018 ITEK stock ended at $3.04. During the day the stock fluctuated 0% from a day low at $3.04 to a day high of $3.04.
90 days $1.96 $3.25
52 weeks $0.85 $3.80

Historical Inotek Pharmaceuticals Corporation prices

Date Open High Low Close Volume
Oct 04, 2017 $2.00 $2.11 $1.99 $2.04 654 703
Oct 03, 2017 $1.95 $2.04 $1.94 $2.04 1 122 533
Oct 02, 2017 $1.78 $2.01 $1.77 $1.94 1 902 134
Sep 29, 2017 $1.73 $1.83 $1.67 $1.78 1 267 473
Sep 28, 2017 $1.74 $1.77 $1.66 $1.72 1 074 327
Sep 27, 2017 $1.68 $1.73 $1.65 $1.72 1 575 223
Sep 26, 2017 $1.65 $1.77 $1.61 $1.66 1 794 332
Sep 25, 2017 $1.55 $1.71 $1.53 $1.64 2 399 046
Sep 22, 2017 $1.54 $1.57 $1.46 $1.55 1 371 034
Sep 21, 2017 $1.43 $1.55 $1.42 $1.52 1 859 972
Sep 20, 2017 $1.35 $1.53 $1.32 $1.41 1 654 034
Sep 19, 2017 $1.30 $1.37 $1.25 $1.36 890 393
Sep 18, 2017 $1.37 $1.42 $1.28 $1.31 1 701 677
Sep 15, 2017 $1.29 $1.41 $1.22 $1.31 3 879 754
Sep 14, 2017 $1.19 $1.34 $1.11 $1.28 3 608 088
Sep 13, 2017 $1.00 $1.28 $0.96 $1.22 9 338 447
Sep 12, 2017 $1.03 $1.05 $1.02 $1.05 165 625
Sep 11, 2017 $1.05 $1.06 $1.00 $1.02 342 392
Sep 08, 2017 $1.05 $1.05 $1.04 $1.04 181 199
Sep 07, 2017 $1.03 $1.08 $1.01 $1.03 720 973
Sep 06, 2017 $1.00 $1.06 $1.00 $1.01 433 370
Sep 05, 2017 $1.01 $1.05 $0.99 $1.02 433 890
Sep 01, 2017 $1.04 $1.04 $0.99 $1.02 292 268
Aug 31, 2017 $0.98 $1.05 $0.98 $1.02 598 541
Aug 30, 2017 $1.02 $1.05 $0.97 $1.00 434 095
Click to get the best stock tips daily for free!

About Inotek Pharmaceuticals Corporation

Inotek Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for glaucoma and other diseases of the eye in the United States. The company’s lead product candidate includes Trabodenoson, a monotherapy that is in Phase III clinical trials for lowering IOP by restoring the eye’s natural pressure control mechanism. It is also developing Trabodenoson plus La... ITEK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT